Home parenteral nutrition (HPN) is a validated technique for patients with various intestinal disease leading to chronic malabsorption or obstruction, whatever the aetiology. Intravascular catheter-related bloodstream infections (CRBSI) is the more frequent complication of patients with HPN and an important cause of morbidity and mortality in these patients. Moreover, CRBSI often recur after a first treatment of the catheter with a combination of an antibiotic lock on the catheter and systemic intravenous antibiotics. In more than 50 % of the cases, another CRBSI will occur in a median delay of 5 months. The aim of the study is to evaluate the efficacy of a taurolidine lock secondary prophylaxis on CRBSI recurrence in HPN patients. Study population is separated in 2 groups, the first one receiving the Taurolock and the second one receiving a placebo. This is a randomized double-blind six-month study.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Enrollment
39
2 mL of taurolidine instillate on the intravascular catheter after each parenteral nutrition session for a duration of 6 months
2 mL of physiologic serum instillate on the intravascular catheter after each parenteral nutrition session for a duration of 6 months
APHP Beaujon Hospital
Clichy, France
UH of Grenoble
Grenoble, France
UH of Lille
Lille, France
UH of Lyon
Lyon, France
UH of Nice
Nice, France
University Hospital of Rouen
Rouen, France
UH of Toulouse
Toulouse, France
Number of recurrence of catheter-related infection in each group
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.